DBNETS conference 2026
The Dutch Belgian NeuroEndocrine Tumour Society (DBNETS) is pleased to invite you to its fourth conference.
When?
Thursday 01/10/2026Where?
Iers College, LeuvenFor who?
Price
Free4th edition
The Dutch Belgian NeuroEndocrine Tumour Society (DBNETS) is delighted to invite you to its fourth conference. We are creating a platform for medical specialists, researchers and patient representatives specialising in neuroendocrine tumours (NET) in the Netherlands and Belgium.
We look forward to welcoming you at the Iers College, Leuven, on Thursday 1 October 2026.
Programme
Session 1: Controversies in NET
10:30 Opening
Timon Vandamme – Chair of DBNETS
Systemic vs. surgical management in stage IV disease
10:45 The liver: surgery
Bart Bracke (NETwerk)
10:55 The liver: systemic management
Annemiek Walenkamp (UMCG)
11:05 Discussion
11:15 Mesenteric disease: prophylactic resection
Wieke Verbeek (AvL-UMCU)
11:25 Mesenteric disease: resection on indication
Willemijn van der Kleij (Amsterdam UMC)
11:35 Discussion
Alpha-PRRT vs beta-PRRT
11:45 The future is alpha
Christophe Deroose (UZ Leuven)
11:55 The future is beta
Ionnis Karfis (HUB)
12:05 Discussion
12:15 Patient perspective
Faye Tukker & Dirk Van Genechten
12:30 Lunch
Session 2: Complex case studies – MDO
13:45 Insulinoma
EMC / UMCG
14:15 Carcinoid syndrome in lung NET
AvL-UMCU / UZ Leuven
14:45 NEC
NET Centre South / NETwerk
15:15 Locally advanced pNET
HUB / “DBNET panel”
15:45 Coffee break
Session 3
16:15 Combination therapy with Lu-PRRT
Tessa Brabander (EMC)
16:35 SSA following progression in non-functional NETs - retroSAUNA
Siddharth Chhjalani (NETwerk)
16:55 EMR and ESD in gastric/rectal NETs
Dominique Clement (NET Centre South)
17:15 Highlights of the year
Willem Lybaert (NETwerk)
17:45 Closing remarks
Christophe Deroose - local organising committee
18:00 Walking dinner
Made possible with the support of:
Abstract submission guidelines
For its 4th installmenet, DBNETS will host poster presentations during the conference. In additon, the best three posters will be awarded with a poster prize. Please submit your abstract to info@dbnets.eu before 23 August 2026.
More information:
General requirements
- All abstracts must be written in English.
- The maximum length is 250 words (excluding title, authors, and affiliations).
- Abstracts that exceed the word limit or do not follow the required structure will not be considered.
- Submissions are open to translational and clinical research.
Required structure
Abstracts must follow this structure exactly, using the headings below:
- Title
- Authors and Affiliations
- Background
- Methods
- Results
- Conclusion
Abstracts that deviate from this format will not be reviewed.
Formatting rules
- Do not include references, tables, or figures.
- All abbreviations must be spelled out at first mention.
- Use clear and concise scientific language.
Type of contribution
All accepted submissions will be presented as posters.
Selection criteria
Abstracts will be evaluated based on:
- Scientific quality
- Relevance to the NEN research and clinical practice
Submission process
- Submit your abstract by email to: info@dbnets.eu
- Attach your abstract as a PDF document.
- Use the following email subject line: DBNETS abstract
Deadline and confirmation
- Submission deadline: 23 August 2026
- A confirmation email will be sent upon successful receipt of your abstract.
Example abstract (template):
Title
Concise and informative title reflecting the content of the study
Authors and affiliations
First Author¹, Second Author², Third Author¹
¹Department, Institution, City, Country
²Department, Institution, City, CountryBackground
Briefly describe the scientific context and rationale for the study. Clearly state the objective or research question.
Methods
Describe the study design, population, methods, and analytical approach. Provide enough detail to understand how the study was conducted.
Results
Summarize the key findings, including relevant data. Avoid vague statements; provide specific results where possible.
Conclusion
State the main conclusions and their relevance. Highlight the importance of the findings for translational or clinical research.